Hasil Pencarian - Roger B Cohen

  • Menampilkan 1 - 12 hasil dari 12
Perbaiki Hasil
  1. 1
    Anti-TNF Therapy and Malignancy – A Critical Review

    Anti-TNF Therapy and Malignancy – A Critical Review oleh Roger B Cohen, Karen A Dittrich

    Diterbitkan 2001-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Immunotherapy for head and neck cancer: latest developments and clinical potential

    Immunotherapy for head and neck cancer: latest developments and clinical potential oleh Joshua M. Bauml, Roger B. Cohen, Charu Aggarwal

    Diterbitkan 2016-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer

    The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer oleh Mohamedtaki A Tejani, Roger B Cohen, Ranee Mehra

    Diterbitkan 2010-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer

    Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer oleh Lova Sun, MD, Charu Aggarwal, MD, MPH, Roger B. Cohen, MD

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic

    Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic oleh Vivek Nimgaonkar, Charu Aggarwal, Abigail T. Berman, Peter Gabriel, Lawrence N. Shulman, John Kucharczuk, Megan Roy, Joshua M. Bauml, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

    Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC oleh David J. Cantor, MD, PhD, Christiana Davis, MD, Christine Ciunci, MD, MSCE, Charu Aggarwal, MD, MPH, Tracey Evans, MD, Roger B. Cohen, MD, Joshua M. Bauml, MD, Corey J. Langer, MD

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series

    Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series oleh Robert S. Zhang, Allison Padegimas, Kathleen M. Murphy, Peter T. Evans, Carli J. Peters, Christopher M. Domenico, Mahesh K. Vidula, Paul J. Mather, Marisa Cevasco, Roger B. Cohen, Joseph R. Carver, Rupal P. O’Quinn

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma. oleh Bert H O'Neil, John M Wallmark, David Lorente, Elena Elez, Judith Raimbourg, Carlos Gomez-Roca, Samuel Ejadi, Sarina A Piha-Paul, Mark N Stein, Albiruni R Abdul Razak, Katia Dotti, Armando Santoro, Roger B Cohen, Marlena Gould, Sanatan Saraf, Karen Stein, Sae-Won Han

    Diterbitkan 2017-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory Papillomatosis

    Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurre... oleh Charu Aggarwal, Roger B. Cohen, Matthew P Morrow, Kimberly A Kraynyak, Albert J Sylvester, Jocelyn Cheung, Kelsie Dickerson, Veronique Schulten, Dawson Knoblock, Elisabeth Gillespie, Joshua M. Bauml, Jian Yan, Malissa Diehl, Jean Boyer, Michael Dallas, J. Joseph Kim, David B Weiner, Jeffrey M. Skolnik

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer

    Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer oleh Nikhil Yegya-Raman, Timothy P. Kegelman, Sang Ho Lee, Michael J. Kallan, Kristine N. Kim, Jyotsna Natarajan, Matthew P. Deek, Wei Zou, Shannon E. O'Reilly, Zheng Zhang, William Levin, Keith Cengel, Gary Kao, Roger B. Cohen, Lova L. Sun, Corey J. Langer, Charu Aggarwal, Aditi P. Singh, Rupal O'Quinn, Bonnie Ky, Aditya Apte, Joseph Deasy, Ying Xiao, Abigail T. Berman, Salma K. Jabbour, Steven J. Feigenberg

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial

    Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial oleh Xiaoyu Zhang, Anthony M Joshua, Sanjeev Kaul, Scott Antonia, Robert L Ferris, Roger B Cohen, Ezio Bonvini, Jan Baughman, Victoria Atkinson, Charu Aggarwal, Nicholas Vogelzang, Osama Rahma, Mahesh Seetharam, Yanyan Lou, Anthony Tolcher, Fernanda I Arnaldez, Amy Prawira, Ralph Hauke, Vinod Ganju, Andrew Weickhardt, Dan P Zandberg, Arash Rezazadeh Kalebasty, Alex A Adjei, Ariel Birnbaum, Rosetta Cavallo, Linda Peng, Paul A Moore, Stacie M Goldberg, Nehal J Lakhani

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

    Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study oleh Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: